GAITHERSBURG, Md., March 9 /PRNewswire-FirstCall/ -- Iomai Corporation today announced that Stanley C. Erck, the company’s president and chief executive officer, will present at Cowen and Company’s 27th Annual Health Care Conference in Boston. Mr. Erck will speak Monday, March 12 at 2:25 p.m. A breakout will follow the session.
Erck will speak on Iomai’s development of patch-based, needle-free vaccines and immunostimulants for use in influenza, pandemic influenza and travelers’ diarrhea. The company in January was awarded a $128 million contract from the Department of Health and Human Services for research on a dose-sparing patch for use with a pandemic influenza vaccine.
The conference will be held at the Boston Marriott Copley Place.
To access the live audio webcast or the subsequent archived recording, log on to the Investor Relations section on the Overview page of the Iomai website at www.iomai.com. Please connect to Iomai’s website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.
ABOUT IOMAI CORPORATION
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin (Langerhans cells) to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. Iomai currently has four product candidates in development: three targeting influenza and pandemic flu and one to prevent E. coli-related travelers’ diarrhea. For more information on Iomai, please visit www.iomai.com.
Iomai Corporation
CONTACT: Russell P. Wilson, Senior Vice President, Chief Financial Officerand General Counsel, Iomai Corporation, +1-301-556-4478,investors@iomai.com; or Brian Reid of WeissComm Partners, Inc.,+1-703-402-3626, breid@weisscommpartners.com, for Iomai Corporation
Web site: http://www.iomai.com/
